Alexion's 2Q Soliris sales, profits jump - Hartford Business
Thu, 22 Jul 2010 15:39:14 GMT+00:00
, profits jump Hartford Business Sales of the drug, Soliris , grew 36 percent to $125.8 million in the latest quarter from $92.3 million in the 2009 second quarter amid growing patient ... 'Steady' sales growth helps boost profits at Alexion Waterbury Republican American Alexion Reports Second Quarter 2010 Results MarketWatch (press release) Alexion Q2 profit beats Street, keeps 2010 view Reuters Zacks.com  - RTT News  - Bradenton Herald

Alexion Hoping Its Soliris Is That Rare Wonder Drug - Investor's Business Daily
Thu, 15 Jul 2010 22:31:42 GMT+00:00
Is That Rare Wonder Drug Investor's Business Daily Alexion on Wednesday is expected to report that second-quarter sales jumped 36% from the year-earlier quarter to $125.8 million. Analysts expect per-share ...

The Price Of Ultra-Safe Drugs - Forbes (blog)
Fri, 16 Jul 2010 14:57:51 GMT+00:00
Forbes (blog) The potential sales a drug has to reach to be a good bet for a company when development times get so long is very high, he argues. ...